Přejít k hlavnímu obsahu

Srovnal Josef M.D., Ph.D.

Journals

CHALOUPKOVA, Z., A. BALZEROVA, Z. MEDRIKOVA, J. SROVNAL, M. HAJDÚCH, K. CEPE, V. RANC, R. ZBOŘIL
Label-free determination and multiplex analysis of DNA and RNA in tumor tissues. Applied Materials Today. 2018, 12(2018), 85-91, ISSN: 2352-9407,
SROVNAL, J., Z. CAPKOVA, P. CAPKOVA, M. PROCHAZKA, M. HAJDÚCH
Duplication of 9p24.3 in three unrelated patients with autistic spectrum disorder. Molecular Genetics and Metabolism. 2021, 132, 136-136, ISSN: 1096-7192,
POTĚŠIL, J., F. KOPŘIVA, P. DŽUBÁK, M. GODOVA, L. RADOVÁ, J. SROVNAL, V. MIHÁL, M. HAJDÚCH
Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults. Central European Journal of Immunology. 2013, 38(4), 518-529, ISSN: 1426-3912,

Open positions

Projekt: Diagnostics and therapy of rare diseases
Vedoucí: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium
Souhrn: 2 places in full-time study
Projekt: New prognostic and predictive factors in solid tumors
Vedoucí: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
K dispozici: 3
Určeno pro: Doktorské studium
Souhrn: 3 places in full-time or combined form of study
Projekt: New prognostic and predictive factors in solid tumors
Vedoucí: Srovnal Josef M.D., Ph.D., Hajdúch Marián M.D., Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium
Souhrn: Cancer is the second leading cause of death in the western countries. Early diagnosis and targeted therapy improve the therapeutic outcome. With the emergence of new biotechnologies, diagnosis can be made early and precisely, and the knowledge of tumor molecular genetics can identify the most appropriate therapy for a particular patient. The sensitivity of modern molecular methods makes it possible to characterize the tumor properties from sites remote from the primary tumor using patient's blood. The subject of the offered study program is the identification of new prognostic and predictive biomarkers of cancer using liquid biopsies. This is particularly the analysis of circulating tumor cells (CTCs), circulating free tumor DNA (ctDNA) and circulating miRNAs. The aim of the project is to further implement a liquid biopsy concept into the diagnosis and therapy monitoring of solid tumors, especially colorectal, breast, lung and CNS tumors. These include therapy response and resistance monitoring, identifying new therapeutic targets and estimating disease prognosis. The project will provide training in widely-used, transferable techniques, including circulation tumor cells capture system, digital droplet PCR, reverse-transcription qPCR, RNA-seq, single cell analyses, xenografts models and other multi-omics methods. We are looking for candidates with a background in Molecular Biology, Medicine, Cell Biology or a related area, who are enthusiastic about investigating novel approaches in cancer diagnostic that have significant potential for public health.
Projekt: Diagnosis and treatment of rare diseases
Vedoucí: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium
Projekt: New prognostic and predictive factors in solid tumors
Vedoucí: Hajdúch Marián M.D., Ph.D., Srovnal Josef M.D., Ph.D., Koudeláková Vladimíra Ph.D.
K dispozici: 3
Určeno pro: Doktorské studium
Projekt: Liquid biopsies in experimental and clinical oncology
Vedoucí: Srovnal Josef M.D., Ph.D., Koudeláková Vladimíra Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium